Skip to main content
Log in

Liver fibrosis staging with diffusion-weighted imaging: a systematic review and meta-analysis

  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

A meta-analysis was performed to assess the diagnostic performance of diffusion-weighted imaging (DWI) in liver fibrosis (LF) staging.

Methods

We conducted a comprehensive literature search to identify relevant articles. Diagnostic data were extracted for each METAVIR fibrosis stage (F0–F4). A bivariate binomial model was used to combine sensitivities and specificities. Summary receiver operating characteristics (SROC) curves were performed and areas under SROC curve (AUC) were calculated to indicate diagnostic accuracies. Subgroup analyses were performed between different study characteristics.

Results

Twelve studies met the inclusion criteria for LF ≥F1, 16 for ≥F2, 18 for ≥F3, and 12 for F4. AUCs of DWI were 0.8554, 0.8770, 0.8836, and 0.8596 for ≥F1, ≥F2, ≥F3, and F4, respectively. Subgroup analyses showed that for LF ≥F2 and ≥F3, maximal b values (b max) ≥ 800 s/mm2 performed significantly better than b max < 800 s/mm2. The diagnostic accuracies of 3.0 T and intravoxel incoherent motion (IVIM)-DWI were significantly higher than those of 1.5 T and conventional DWI for diagnosing liver cirrhosis (F4).

Conclusions

DWI is a reliable noninvasive technique with good diagnostic accuracy for LF staging. Using b max ≥ 800 s/mm2, high-field strength (3.0 T) and IVIM-DWI can optimize the diagnostic performance of DWI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

ADC:

Apparent diffusion coefficient

AUC:

Area under SROC curve

b max :

Maximal b value

CI:

Confidence interval

CLD:

Chronic liver disease

DWI:

Diffusion-weighted imaging

ECM:

Extracellular matrix

FN:

False-negative

FP:

False-positive

HCC:

Hepatocellular carcinoma

IVIM:

Intravoxel incoherent motion

MR:

Magnetic resonance

MRE:

Magnetic resonance elastography

MRI:

Magnetic resonance imaging

NLR:

Negative likelihood ratio

PLR:

Positive likelihood ratio

QUADAS-2:

Quality assessment of diagnostic accuracy studies-2

SNR:

Signal-to-noise ratio

SROC:

Summary receiver operating characteristics

TN:

True-negative

TP:

True-positive

References

  1. Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 383:1749–1761

    Article  PubMed  Google Scholar 

  2. Wallace K, Burt AD, Wright MC (2008) Liver fibrosis. Biochem J 411:1–18

    Article  CAS  PubMed  Google Scholar 

  3. D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis. A systematic review of 118 studies. J Hepatol 44:217–231

    Article  PubMed  Google Scholar 

  4. Kuramitsu K, Sverdlov DY, Liu SB, et al. (2013) Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation. Am J Pathol 183:182–494

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Marcellin P, Gane E, Buti M, et al. (2013) Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet 381:468–475

    Article  CAS  PubMed  Google Scholar 

  6. Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344:495–500

    Article  CAS  PubMed  Google Scholar 

  7. Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38:1449–1457

    Article  PubMed  Google Scholar 

  8. Castéra L, Foucher J, Bernard PH, et al. (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51:828–835

    PubMed  Google Scholar 

  9. Ferraioli G, Tinelli C, Dal Bello B, et al. (2012) Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology 56:2125–2133

    Article  PubMed  Google Scholar 

  10. Huwart L, Sempoux C, Vicaut E, et al. (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135:32–40

    Article  PubMed  Google Scholar 

  11. Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254:47–66

    Article  PubMed  Google Scholar 

  12. Luciani A, Vignaud A, Cavet M, et al. (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging—pilot study. Radiology 249:891–899

    Article  PubMed  Google Scholar 

  13. Faria SC, Ganesan K, Mwangi I, et al. (2009) MR imaging of liver fibrosis: current state of the art. Radiographics 29:1615–1635

    Article  PubMed  Google Scholar 

  14. Cassinotto C, Feldis M, Vergniol J, et al. (2015) MR relaxometry in chronic liver diseases: comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity. Eur J Radiol 84:1459–1465

    Article  PubMed  Google Scholar 

  15. Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis. Hepatology 56:239–247

    Article  PubMed  Google Scholar 

  16. Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825–832

    Article  CAS  PubMed  Google Scholar 

  17. Whiting PF, Rutjes AW, Westwood ME, et al. (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536

    Article  PubMed  Google Scholar 

  18. Honest H, Khan KS (2002) Reporting of measures of accuracy in systematic reviews of diagnostic literature. BMC Health Serv Res 2:4

    Article  PubMed  PubMed Central  Google Scholar 

  19. Arends LR, Hamza TH, van Houwelingen JC, Heijenbrok-Kal MH, HuninkMG Stijnen T (2008) Bivariate random effects meta-analysis of ROC curves. Med Decis Making 28:621–638

    Article  CAS  PubMed  Google Scholar 

  20. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558

    Article  PubMed  Google Scholar 

  21. Dinnes J, Deeks J, Kirby J, Roderick P (2005) A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess 9:1–113

    Article  CAS  Google Scholar 

  22. Sterne JAC, Harbord RM (2004) Funnel plots in meta-analysis. Stata J 4:127–141

    Google Scholar 

  23. Song F, Khan KS, Dinnes J, Sutton AJ (2002) Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 31:88–95

    Article  PubMed  Google Scholar 

  24. Taouli B, Tolia AJ, Losada M, et al. (2007) Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 189:799–806

    Article  PubMed  Google Scholar 

  25. Feier D, Balassy C, Bastati N, et al. (2016) The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis—a multiparametric approach. Eur Radiol 26:539–546

    Article  PubMed  Google Scholar 

  26. Taouli B, Chouli M, Martin AJ, et al. (2008) Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 28:89–95

    Article  PubMed  Google Scholar 

  27. Zhou ML, Yan FH, Xu PJ, et al. (2009) Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging. Zhonghua Yi Xue Za Zhi 89:1757–1761

    PubMed  Google Scholar 

  28. Parente DB, Paiva FF, Oliveira Neto JA, et al. (2015) Intravoxel incoherent motion diffusion weighted MR imaging at 3.0 T: assessment of steatohepatitis and fibrosis compared with liver biopsy in type 2 diabetic patients. Plos One 10:e0125653

    Article  PubMed  PubMed Central  Google Scholar 

  29. Fujimoto K, Tonan T, Azuma S, et al. (2011) Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade. Radiology 258:739–748

    Article  PubMed  Google Scholar 

  30. Lewin M, Poujol-Robert A, Boëlle PY, et al. (2007) Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:658–665

    Article  CAS  PubMed  Google Scholar 

  31. Shi Y, Guo QY, Liao W, Ma Y, Qi WX (2010) MR diffusion weighted imaging for quantification of liver fibrosis in patients with chronic viral hepatitis. Chin J Radiol 1:65–69

    Google Scholar 

  32. Vaziri-Bozorg SM, Ghasemi-Esfe AR, Khalilzadeh O, et al. (2012) Diffusion-weighted magnetic resonance imaging for diagnosis of liver fibrosis and inflammation in chronic viral hepatitis: the performance of low or high B values and small or large regions of interest. Can Assoc Radiol J 63:304–311

    Article  PubMed  Google Scholar 

  33. Kocakoc E, Bakan AA, Poyrazoglu OK, et al. (2015) Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using different b-values in chronic viral hepatitis. Med Princ Pract 24:522–526

    Article  PubMed  Google Scholar 

  34. Wu CH, Ho MC, Jeng YM, et al. (2015) Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US. Eur Radiol 25:3552–3559

    Article  PubMed  Google Scholar 

  35. Ichikawa S, Motosugi U, Morisaka H, et al. (2015) MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography. J Magn Reson Imaging 42:204–210

    Article  PubMed  Google Scholar 

  36. Ding Y, Rao SX, Zhu T, et al. (2015) Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging. Clin Radiol 70:1096–1103

    Article  CAS  PubMed  Google Scholar 

  37. Hong Y, Shi Y, Liao W, et al. (2014) Relative ADC measurement for liver fibrosis diagnosis in chronic hepatitis B using spleen/renal cortex as the reference organs at 3 T. Clin Radiol 69:581–588

    Article  CAS  PubMed  Google Scholar 

  38. Tokgöz Ö, Unal I, Turgut GG, Yildiz S (2014) The value of liver and spleen ADC measurements in the diagnosis and follow up of hepatic fibrosis in chronic liver disease. Acta Clin Belg 69:426–432

    Article  PubMed  Google Scholar 

  39. Chung SR, Lee SS, Kim N, et al. (2015) Intravoxel incoherent motion MRI for liver fibrosis assessment: a pilot study. Acta Radiol 56:1428–1436

    Article  PubMed  Google Scholar 

  40. Yoon JH, Lee JM, Baek JH, et al. (2014) Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. J Comput Assist Tomogr 38:110–116

    Article  PubMed  Google Scholar 

  41. Chen C, Wang B, Shi D, et al. (2014) Initial study of biexponential model of intravoxel incoherent motion magnetic resonance imaging in evaluation of the liver fibrosis. Chin Med J (Engl) 127:3082–3087

    Google Scholar 

  42. Bonekamp D, Bonekamp S, Ou HY, et al. (2014) Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging. J Magn Reson Imaging 40:1137–1146

    Article  PubMed  Google Scholar 

  43. Bonekamp S, Torbenson MS, Kamel IR (2011) Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol 45:885–892

    Article  PubMed  PubMed Central  Google Scholar 

  44. Wang Y, Ganger DR, Levitsky J, et al. (2011) Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 196:553–561

    Article  PubMed  PubMed Central  Google Scholar 

  45. Patel J, Sigmund EE, Rusinek H, et al. (2010) Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 31:589–600

    Article  PubMed  PubMed Central  Google Scholar 

  46. Sandrasegaran K, Akisik FM, Lin C, et al. (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193:1556–1560

    Article  PubMed  Google Scholar 

  47. Kovač JD, Daković M, Stanisavljević D, et al. (2012) Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases. Eur J Radiol 81:2500–2506

    Article  PubMed  Google Scholar 

  48. Do RK, Chandarana H, Felker E, et al. (2010) Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol 195:671–676

    Article  PubMed  Google Scholar 

  49. Taouli B, Vilgrain V, Dumont E, et al. (2003) Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echoplanar MR imaging sequences: prospective study in 66 patients. Radiology 226:71–78

    Article  PubMed  Google Scholar 

  50. Namimoto T, Yamashita Y, Sumi S, Tang Y, Takahashi M (1997) Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology 204:739–744

    Article  CAS  PubMed  Google Scholar 

  51. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H (1999) Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 210:617–623

    Article  CAS  PubMed  Google Scholar 

  52. Swets JA (1988) Measuring the accuracy of diagnostic systems. Science 240:1285–1293

    Article  CAS  PubMed  Google Scholar 

  53. Koinuma M, Ohashi I, Hanafusa K, Shibuya H (2005) Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 22:80–85

    Article  PubMed  Google Scholar 

  54. Kim AI, Saab S (2005) Treatment of hepatitis C. Am J Med 118:808–815

    Article  CAS  PubMed  Google Scholar 

  55. Ghany MG, Strader DB, Thomas DL, Seeff LB (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49:1335–1374

    Article  CAS  PubMed  Google Scholar 

  56. Ozkurt H, Keskiner F, Karatag O, et al. (2014) Diffusion weighted MRI for hepatic fibrosis: impact of b-value. Iran J Radiol 11:e3555

    PubMed  PubMed Central  Google Scholar 

  57. Poyraz AK, Onur MR, Kocakoc E, Ogur E (2012) Diffusion-weighted MRI of fatty liver. J Magn Reson Imaging 35:1108–1111

    Article  PubMed  Google Scholar 

  58. Le Bihan D, Turner R, MacFall JR (1989) Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: application to molecular diffusion imaging. Magn Reson Med 10:324–337

    Article  PubMed  Google Scholar 

  59. Braithwaite AC, Dale BM, Boll DT, Merkle EM (2009) Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology 250:459–465

    Article  PubMed  Google Scholar 

  60. van den Bos I, Hussain SM, Krestin GP, Wielopolski PA (2008) Liver imaging at 3.0 T: diffusion-induced black-blood echo-planar imaging with large anatomic volumetric coverage as an alternative for specific absorption rate-intensive echo-train spin-echo sequences: feasibility study. Radiology 248:264–271

    Article  PubMed  Google Scholar 

  61. Lee VS, Hecht EM, Taouli B, et al. (2007) Body and cardiovascular MR imaging at 3.0 T. Radiology 244:692–705

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

This study was funded by National Natural Science Foundation of China (Grant Number 81471658).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bin Song.

Ethics declarations

Conflict of interest

All the authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this retrospective type of study, formal consent is not required.

Additional information

Hanyu Jiang and Jie Chen have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, H., Chen, J., Gao, R. et al. Liver fibrosis staging with diffusion-weighted imaging: a systematic review and meta-analysis. Abdom Radiol 42, 490–501 (2017). https://doi.org/10.1007/s00261-016-0913-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-016-0913-6

Keywords

Navigation